α-Lipoc Acid Improve the Short Term Outcomes in Human Liver Transplantation.
“Donor Age or Quality” a Qualitative Analysis of Livers Declined for 830.
Apolipoprotein L1 & Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.
Clostridium difficile Infection in Intestinal Transplant Recipients.
De Novo Donor-Specific Antibodies After Allograft Nephrectomy.
De Novo Donor-Specific Antibody Formation After Kidney Retransplant Is Associated with Specificity Against Class I.
De Novo Use of Everolimus Reduces Late-Onset Cytomegalovirus Primary Disease Occurring After Antiviral Prophylaxis Discontinuation in Kidney Transplant Recipients.
De-Novo Portal Vein Thrombosis After Adult-to-Adult Living Donor Liver Transplantation (LDLT) Does Not Impact on Long-Term Outcome.
Ex Vivo Normothermic Perfusion of Isolated Segmental Porcine Bowel: A Novel Functional Model of the Small Intestine.
In Vitro Optimisation of the Immunotherapeutic Effects of Umbilical Cord Derived MSC.
2017 American Transplant Congress
April 29-May 3, 2017 in Chicago, IL
For more information, visit The Official ATC Congress site.